NEW YORK (AP) — Shares of LipoScience are up on their first day of trading, but the initial public offering of the cholesterol diagnostic test maker priced well below expectations.
The Raleigh, N.C., company sold 5 million shares for $9 each. It had expected a range of $13 to $15 per share and lowered that to between $9 and $10 per share on Thursday.
The shares rose 81 cents, or 9 percent, to $9.81 in morning trading while the broader markets edged higher.
LipoScience Inc. makes a diagnostic test for LDL or "bad" cholesterol that is designed to assess cardiovascular disease risk. It expects to raise about $38.6 million and will use funds for purposes including hiring sales and marketing staff.
The stock trades under the ticker symbol "LPDX."
Bill Clinton sometimes wishes he weren't married to Hillary
After Getting Police Escort, Beyonce Spews Black Lives Matter Message at Super Bowl
Toxic Words | Human Events
Final CNN tracking poll of NH: Trump leads big, Rubio second, Bush and Christie in deep trouble
- The Major Trends in U.S. Income Inequality Since 1947
Donald Trump Just Called Ted Cruz 'A P*ssy' [VIDEO] | RedState
After Youtube Terminated His Account Twice, Hickok45 Found A New Home